Progress in ovarian cancer
- PMID: 9484630
- DOI: 10.1097/00001703-199802000-00010
Progress in ovarian cancer
Abstract
The management of advanced ovarian cancer relies on appropriate surgical cytoreduction in conjunction with appropriate adjuvant chemotherapy. In the past year several studies have continued to support aggressive cytoreduction at the initial operation, including for stage IV disease, as well as in a second-look setting. Ongoing research has identified several agents active in ovarian cancer, yet the optimal first-line regimen has yet to be developed.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous